MedPal AI is one of the few new companies to be brave enough to come to AIM this year. It has raised cash to commercialise its digital health app. There are also plans to incorporate AI in the current product.
Having raised £1.65m net there will be £650,000 spent on technology development and £575,000 on marketing. There is currently a partnership with employee benefits firm Epassi. Management hopes to secure other partnerships.
The share price ended the first day at 6.25p and it has risen to 12.25p (12p/12.5p). This is an impressive start, and the bid/offer spread is relatively narrow for suc...
